Drugs may be as good as surgery for chronic sinusitis
Stephen FellerCALGARY, Alberta, Oct. 30 (UPI) -- Nasal sprays, antibiotics and antihistamines may be as effective as surgery at correcting issues caused by chronic sinus infections, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 30, 2015 Category: Consumer Health News Source Type: news
Drugs May Be as Good as Surgery for Chronic Sinusitis
Title: Drugs May Be as Good as Surgery for Chronic SinusitisCategory: Health NewsCreated: 10/29/2015 12:00:00 AMLast Editorial Review: 10/30/2015 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - October 30, 2015 Category: Allergy & Immunology Source Type: news
Drugs, Surgery May be Equal for Chronic Sinusitis
Study found sufferers who stuck with treatments like nasal sprays saw improvements in quality of life (Source: WebMD Health)
Source: WebMD Health - October 29, 2015 Category: Consumer Health News Source Type: news
Drugs May Be as Good as Surgery for Chronic Sinusitis
Study found sufferers who stuck with treatments like nasal sprays saw improvements in quality of life
Source: HealthDay
Related MedlinePlus Pages: Sinusitis, Surgery (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 29, 2015 Category: Consumer Health News Source Type: news
Intersect ENT files for expanded Propel PMA
Intersect ENT (NSDQ:XENT) said Tuesday it submitted a supplemental premarket approval application to the FDA to expand the indication on its Propel mini steroid releasing implant to cover frontal sinus surgeries.
The new indication would allow the drug-device combo to be used in the frontal sinuses, located behind the eyebrows, the Menlo Park, Calif.-based company said.
“This is an exciting milestone for Intersect ENT. More than 75,000 patients have benefitted from Propel to date and we look forward to broadening access to sustained local steroid delivery to more patients suffering from chronic sinusitis,” CEO...
Source: Mass Device - October 2, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Drug-Device Combinations Food & Drug Administration (FDA) Implants Otolaryngology Ear, Nose & Throat Intersect ENT Inc. Source Type: news
Intersect ENT touts sinus-implant study results
Intersect ENT (NSDQ:XENT) said today results from 3 clinical studies of its Propel, Resolve and Nova products showed positive results. The data was presented at the American Rhinologic Society’s annual meeting in Dallas.
Each of the studies evaluated steroid releasing sinus implants placed in minimally invasive in-office procedures to reduce inflammation for patients with chronic sinusitis, the Menlo Park, Calif.-based company said.
“More than 500,000 patients undergo sinus surgery in the operating room every year, but there are many more suffering from chronic sinusitis who either don’t want to undergo a pro...
Source: Mass Device - September 28, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Drug-Device Combinations Implants Intersect ENT Inc. Source Type: news
Cancer, sinusitis, tinnitus, and exposure to tobacco smoke
(American Academy of Otolaryngology - Head and Neck Surgery) Research to be presented tomorrow at the 2015 Annual Meeting & OTO EXPOSM of the American Academy of Otolaryngology--Head and Neck Surgery Foundation (AAO-HNSF) spans across the otolaryngology specialty. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 27, 2015 Category: Cancer & Oncology Source Type: news
CEOs: The medtech investment climate is improving but getting tighter
By Scott Wooldridge
The climate for investment in medical device companies is improving but getting tighter, as biotech and pharma horn in on the recovering economy, according to a pair of medtech CEOs speaking at last night’s DeviceTalks: Minnesota event.
Entellus Medical (NSDQ:ENTL) CEO Bob White and Martha Shadan, president & CEO at Rotation Medical, spoke with LifeScience Alley CEO Shaye Mandle about the state of the medical device marketplace.
Shadan and White agreed that the climate for raising money in the medtech sector has improved. White, whose company makes minimally invasive therapies to treat c...
Source: Mass Device - September 24, 2015 Category: Medical Equipment Authors: MassDevice Tags: Funding Roundup Orthopedics Otolaryngology Ear, Nose & Throat Wall Street Beat DeviceTalks Entellus Medical Inc. Rotation Medical Inc. Source Type: news
Mistaken Diagnoses Are Much More Common Than You'd Think
WASHINGTON (AP) -- Most people will experience at least one wrong or delayed diagnosis at some point in their lives, a blind spot in modern medicine that can have devastating consequences, says a new report that calls for urgent changes across health care. Getting the right diagnosis, at the right time, is crucial, but Tuesday's Institute of Medicine report found diagnostic errors get too little attention. The biggest needed change: "Patients are central to a solution," said Dr. John Ball of the American College of Physicians, who chaired the IOM committee. That means better teamwork between health providers - doctors, nur...
Source: Science - The Huffington Post - September 23, 2015 Category: Science Source Type: news
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include treatment of Chagas disease, whether tired surgeons make more mistakes, sleep and common colds, and management of chronic sinusitis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 5, 2015 Category: Cardiology Source Type: news
Most Effective Treatments for Chronic Sinusitis Outlined (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM
Available evidence supports daily use of topical intranasal corticosteroids plus saline irrigation as first-line treatment for chronic sinusitis in adults, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 2, 2015 Category: Primary Care Source Type: news
Variation In Antibiotic Prescribing Among VA Physicians
A new study in the Annals of Internal Medicine takes a detailed look at the huge problem of overprescribing antibiotics for outpatients with upper respiratory tract infections (URIs). Such acute respiratory infections (ARIs) are often viral in origin, and therefore won’t be helped by antibiotics. Instead, the overuse drives antibiotic resistance. Despite guidelines, most outpatient antibiotics are still prescribed for ARIs—bronchitis, sinusitis, laryngitis, “colds,” and ear infections. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 20, 2015 Category: Pharmaceuticals Authors: Judy Stone Source Type: news
Intersect Ent launches Nova sinus implant trial
Intersect ENT (NSDQ:XENT) said yesterday it enrolled the 1st patient in a trial of its Nova bioabsorbable steroid releasing sinus implant.
The implant is designed to prop open the sinuses and deliver anti-inflammatory medication after surgical interventions, the Menlo Park, Calif.-based company said.
“Clinical evidence to date has shown that Propel and Propel mini meaningfully improve the outcomes of patients undergoing ethmoid sinus surgery. Patients with chronic sinusitis may benefit similarly from a steroid-releasing implant as part of treatment of the frontal sinus. I am pleased to be involved with the clinical a...
Source: Mass Device - July 9, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Drug-Device Combinations Otolaryngology Ear, Nose & Throat Intersect ENT Inc. Source Type: news
Drug firm Jubilant Life Sciences gets USFDA nod for generic levofloxacin tablets
The drug is used to treat adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections etc. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 23, 2015 Category: Pharmaceuticals Source Type: news
Tackling chronic sinusitis by addressing underlying factors
(American Chemical Society) The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They describe their work in the ACS journal Molecular Pharmaceutics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2015 Category: Global & Universal Source Type: news
